Zoledronic acid infusion and orbital inflammatory disease

New England Journal of Medicine

Volumn 359, Issue 13, 2008, Pages 1410-1411

  Sharma, Neil S ^a   Ooi, Ju Lee ^a   Masselos, Katherine ^b   Hooper, Michael J ^c   Francis, Ian C ^d  

^a SYDNEY EYE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METHYLPREDNISOLONE; PREDNISONE; ZOLEDRONIC ACID;

ADULT; BONE NECROSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; LETTER; MALE; ORBIT INFLAMMATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 52649091354     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0803366     Document Type: Letter

References (5)

1. Fraunfelder FW, Fraunfelder FT. Bisphosphonates and ocular inflammation. N Engl J Med 2003;348:1187-8.
2. Chang AA, Bank A, Francis IC, Kappagoda MB. Clinical exophthalmometry: a comparative study of the Luedde and Hertel exophthalmometers. Aust N Z J Ophthalmol 1995;23:315-8.
3. Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology (Oxford) 2001;40:956-7.
4. Subramanian PS, Kerrison JB, Calvert PC, Miller NR. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol 2003;121:1335-6.
5. Kunzmann V, Bauer E, Wilhelm M. γ/δ T-cell stimulation by pamidronate. N Engl J Med 1999;340:737-8.